Tuberculous keratitis
ICD-10 A18.52 is a billable code used to indicate a diagnosis of tuberculous keratitis.
Tuberculous keratitis is an ocular manifestation of tuberculosis (TB) that primarily affects the cornea. It is characterized by inflammation of the cornea due to the presence of Mycobacterium tuberculosis. This condition can lead to significant visual impairment if not diagnosed and treated promptly. Symptoms may include redness, pain, photophobia, and blurred vision. Diagnosis typically involves a thorough clinical examination, including slit-lamp examination, and may be supported by microbiological tests such as cultures or PCR for Mycobacterium tuberculosis. In some cases, chest X-rays may be performed to assess for pulmonary involvement. Treatment usually involves a combination of anti-tuberculous medications, such as isoniazid, rifampicin, ethambutol, and pyrazinamide, tailored to the patient's specific needs and drug susceptibility patterns. Monitoring for drug resistance is crucial, as multi-drug resistant TB can complicate treatment. Public health implications are significant, as TB is a contagious disease; therefore, contact tracing and isolation procedures may be necessary to prevent further transmission. Regular follow-up is essential to assess treatment efficacy and manage any potential complications.
Detailed ocular examination findings, including slit-lamp results and visual acuity assessments.
Patients presenting with corneal ulcers, redness, and pain, particularly in those with a history of TB.
Documentation must specify the relationship between TB and ocular symptoms to support the diagnosis.
Comprehensive history of TB exposure, diagnostic test results, and treatment plans.
Patients with systemic TB presenting with ocular symptoms or those with a known history of TB.
Coordination with ophthalmology for comprehensive management and documentation of ocular findings.
Used when a comprehensive eye examination is performed to assess tuberculous keratitis.
Detailed findings from the examination, including visual acuity and slit-lamp results.
Ophthalmologists should ensure that all relevant findings are documented to support the diagnosis.
Common symptoms include eye pain, redness, photophobia, and blurred vision. Patients may also experience tearing and discharge.
Diagnosis is made through clinical examination, including slit-lamp evaluation, and may be confirmed with microbiological tests such as cultures or PCR for Mycobacterium tuberculosis.
Treatment typically involves a combination of anti-tuberculous medications, tailored to the patient's specific needs and drug susceptibility patterns.
Public health measures include contact tracing, isolation procedures for infectious patients, and monitoring for drug resistance.
